英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

Malay    音标拼音: [m'ele]
n. 马来
a. 马来人的,马来语的

马来马来人的,马来语的

Malay
adj 1: of or relating to or characteristic of the people or
language of Malaysia and the northern Malay Peninsula and
parts of the western Malay Archipelago; "Malay peoples";
"Malayan syllable structure" [synonym: {Malay}, {Malayan}]
n 1: a member of a people inhabiting the northern Malay
Peninsula and Malaysia and parts of the western Malay
Archipelago [synonym: {Malay}, {Malayan}]
2: a western subfamily of Western Malayo-Polynesian languages


请选择你想看的字典辞典:
单词字典翻译
Malay查看 Malay 在百度字典中的解释百度英翻中〔查看〕
Malay查看 Malay 在Google字典中的解释Google英翻中〔查看〕
Malay查看 Malay 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Immune Checkpoint Inhibitors - NCI - National Cancer Institute
    Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause
  • Immune Checkpoint Inhibitors and Their Side Effects
    Immune checkpoint inhibitors, like PD-1 or PD-L1 inhibitors, are treatments that help the immune system recognize and attack cancer cells Learn more here
  • PD-1 and PD-L1 inhibitors - Wikipedia
    The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001 [6] Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab As of 2017, more than 500 clinical trials involving PD-1 and PD-L1 inhibitors have been conducted in more than 20,000 patients [7] By the
  • PD-1 and PD-L1: architects of immune symphony and . . . - Frontiers
    Recent advancements in the combination of immunotherapy with chemotherapy, radiation, and surgical procedures to enhance patient outcomes have also been highlighted Overall, this study offers an in-depth overview of the significance of PD-1 PD-L1 in cancer immunotherapy and its future implications in oncology
  • PD-L1 and PD-1: Immunotherapy Checkpoint Inhibitors
    A type of cancer immunotherapy targets PD-1 or PD-L1 with checkpoint inhibitors designed to block one or the other Learn more about testing and results
  • PD1 and Immunotherapy: What You Need to Know | Dana-Farber
    Some of the most effective immunotherapy agents for cancer are drugs known as checkpoint inhibitors, which, by blocking PD-1, PD-L1 and related proteins, give the immune system a go-ahead to attack tumor cells Dana-Farber scientist Gordon Freeman, PhD, and his colleagues played a major role in the development of some of these inhibitors
  • PD-L1 degradation pathway and immunotherapy for cancer
    Although some specific drugs induce PD-L1 degradation and increase antitumor activity, the combination of these drugs with PD-L1 PD-1 blockade significantly enhances cancer immunotherapy
  • PDL1 (Immunotherapy) Tests: MedlinePlus Medical Test
    PDL1 (Immunotherapy) Tests What is a PD-L1 Test? A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called programmed-death ligand 1 (PD-L1) is found on the cancer cells Normally, PD-L1 is found on certain healthy cells
  • Immunoscore immune checkpoint using spatial quantitative . . .
    Anti-PD-1 and PD-L1 antibodies (mAbs) are approved immunotherapy agents to treat metastatic non-small cell lung cancer (NSCLC) patients Only a minority of patients responds to these treatments and biomarkers predicting response are currently lacking
  • Targeting novel regulated cell death: Ferroptosis, pyroptosis . . .
    Furthermore, targeting cell death signalling pathways in combination with anti‐PD1 PD‐L1 therapies holds promise as a prospective immunotherapy strategy for tumour treatment This review summarises the novel roles of ferroptosis, pyroptosis, and necroptosis in anti‐PD‐1 PD‐L1 immunotherapy





中文字典-英文字典  2005-2009